You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. Forums. British Columbia, Selkirk Mountains. Bumping up this thread as $3. ASX - Day Trading. ASX - Short Term Trading. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. 76 (-1. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. . , page-2. . A handy 10 bags from here with seemingly little risk. 333334. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. *Close price adjusted for splits. Notice of Annual General Meeting/Proxy FormInvex Receives Written Response from FDA on Type C MeetingNotification of cessation of securities - IXC. Created with Sketch. Currency in USD 38. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. A new thread to put trading comments / reasoning / opinions in. Invex Receives Approval for Paediatric Plan from the EMA, page-3. Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. LoginJoin Now. Contrast that to data from Wales in 2017 which suggests that. 06KBNotification of cessation of securities - IXC. Share I've got no issues with it. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. Created with Sketch. 0. Last updated 15. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. Notice of Quarterly Investor Call. I think having this out we can discuss on the way. ASX - General. 31% more bullish than other Healthcare sector stocks. . June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. I think having this out we can discuss on the way. . 4KB OECCreated with Sketch. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Latest Posts. I think having this out we can discuss on the way. Share "Online registration will open 30 minutes before the Meeting. , page-136. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. . 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. ASX - By Stock. Notice of Annual General Meeting/Proxy Form, page-2. 1. 0. Invex Therapeutics Ltd. 38 Biotechnology stocks are valued based on a risk. ASX - Day Trading. IXC needs to be proactive and release a statement. . 026. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. 40 in May 2020 and has only fallen over the subsequent 36 months. Reply. ASX - By Stock. 1950. Issue of Tranche 1 Placement Shares and Appendix 2A. Join the HotCopper ASX share market forum today for free. Created with Sketch. Timeline Annotations of the IXC Chart Story Thus Far - IXC IPO'd in mid 2019 with Phase II data due Mid 2020, stock performs very well on IPO with tight T20 - The stock rose in anticipation for the Mid 2020 Phase II data read out in early 2020 - Before crashing alongside the Covid 19 Market Crash Hysteria in March 2020 AND all volume the last 18 months has led to a higher T20 ownership) meanwhile we have a mere 3 posts regarding an IXC job listing for a CMO that's description can be interpreted as hinting at a second indication. 91%) As of 03:35PM EST. ASX - Day TradingCreated with Sketch. Notification of cessation of securities - IXC. Probably been disappointed like all of usCreated with Sketch. Market open. IXC Valuation Report MST. Latest Posts ForumsHalf Yearly Report and AccountsWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. . ASX - By Stock. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. Advertise on HotCopper. ASX - By Stock. It's essentially a cashed up shell company right now it. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. . Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you. , page-5. 7% #asx #ausbiz 23 Jun 2023 06:06:11. IXC Price at posting: 45. ASX - Short Term Trading. Only took that large seller to sell, now liquidity has dried up and. ASX - General. . Webinvest Pty Ltd<Olsb Unit A/C>. Market . Created with Sketch. Created with Sketch. . ASX - By Stock. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Last updated 10. Created with Sketch. 0. ASX - By Stock. Created with Sketch. 59). If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Very tempted to buy them back today at 19c. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. Although, IXC is trading about 3-4x lower than what I expect it to be. ASX - General. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. 43 Sentiment: Buy Disclosure: Held. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. 30 to $15 in the space of 1 and half years Bios move fast when value is recognised. Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Notice of Investor Call and Presentation, page-2. ASX - General. Join the HotCopper ASX share market forum today for free. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. . Notification of cessation of securities - IXC. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. ASX - Day TradingAnother day…another approval. . Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 76 (-1. ASX - By Stock. ASX - Day TradingCreated with Sketch. Created with Sketch. . 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. 31% more bullish than other Healthcare sector stocks. 0. Sentiment for Invex Therapeutics Ltd. IXC Price at posting: 79. ASX - General. a shell trading below cash backing, ripe. Created with Sketch. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. . Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. . Created with Sketch. Transparency is our policy. ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. . 59pm 09/11/2023 ? HotCopper has news, discussion, prices and market data on INCITEC PIVOT LIMITED. . Created with Sketch. Forex. 375,000. . . Forums. ASX - By Stock. . 79 -0. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. When can we expect some update or. ASX - By Stock. Last updated 15. Trading HaltIXC Valuation Report MST. Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . Charts. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. ASX - Short Term Trading. ASX - Short Term Trading. Charts. Folks say we are pioneers of craft ice cream in Victoria. , page-3. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. Results of MeetingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Learn how it impacts everything we do. Forums. 4. Created with Sketch. Charts. *Close price adjusted for splits. ASX - Day Trading. ASX - Short Term Trading. ASX - Day Trading. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - By Stock. Share Not unexpected. IXC Valuation Report MST. Notification regarding unquoted securities - IXC Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. 05. Share Appreciate the commentary and post. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. About 90 percent of the U. Created with Sketch. Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. Loading. . ASX - Day TradingHi all, I would like to preface the below summary written prior to the research links as being a heavily simplified summary of the company and the. 1950. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. I knew zero about the fundamentals of IXC. Created with Sketch. Last updated 10. . ASX - By Stock. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not. Read in the announcement, has changed name and he has bought more ixc, page-2. Created with Sketch. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . Can&apos;t see how this doesn&apos;t push up soon, page-508. sentiment based on opinions from HotCopper and others. Wouldn’t surprised me if they turn this company into something else if he keeps buyingCreated with Sketch. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. ASX - Day Trading. Join the HotCopper ASX share market. . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. But since the cash holding is double the market cap, there most likely more upside than down side. Market . Join the HotCopper ASX share market forum today for free. 1956773. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Latest Posts. Commodities. 147,415. I think IXC has the potential to do better. Australian finance news, stock quotes, currency information and blogs0. ASX - By Stock. , page-4. , page-32. IXC has alot of catching up to do. There can't be many left who have a positive association with this stock (apart from seed investors), so I don't think token $10-20k director purchases will change anything. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. Created with Sketch. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. DJPIN. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. Join the HotCopper ASX share market forum today for free. ASX - Day Trading0. ASX - General. , page-2. Market . Latest Posts. IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. See page-34. ASX - General. Latest Posts. These are 2007 numbers. . Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. ASX - By Stock. 40. . Created with Sketch. ASX - By Stock. IXC Price at posting: $1. How many friends and family got out after the last announcementshould have been released at the same time, page-34. Appendix 4E and Annual Report, page-3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. . IXC (ASX) Ann: Trading Halt - HotCopper. This was roughly 50/50 between lost wages and direct medical costs. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch. ASX - General. Market . . RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. IXC Price at posting: 38. 5¢ Sentiment: Buy Disclosure: Held. Invex issued US patent for Traumatic Brain Injury. 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. International Markets. Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. , page-6. Created with Sketch. Latest Posts. Target our investor community with our suite of Hotcopper Advertising. I bought the chart from base lows looking for a trade. A new thread to put trading comments / reasoning / opinions in. Commodities. Forums. Market Cap $102. Is it just me or has IXC gone very quiet. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. Created with Sketch. Charts. ASX - Short Term Trading. Ceasing to be a substantial holder. Market Cap $16. Of course IXC isnt the stock market but its coincidental that selling has stopped around this 17 cents mark which aligns with the old trend line from back in the days. Andrew Forrest , or his entities have been involved with IXC since inception. Proposed Capital Return to Shareholders of $14. 2. . 3¢. Created with Sketch. 64440. Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. I guess that&amp;apos;s why retail performs so poorly on average, so many think they are long term investors but can&amp;apos;t hold onto their shares for more. 19 Per share (Personal Estimate) vs MST Research report of $3. Last edited by ejjwj: 28/06/23. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. ASX - Day TradingCreated with Sketch. Market . ASX - By Stock. com. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. ASX - Short Term Trading. What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. Invex Therapeutics Lists on ASX, page-3. , page-3. 8M ! Add to my watchlist. ASX - Day TradingAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. 0¢ Sentiment: Buy Disclosure: Held. 30 Haven’t supported share price since then on market . Market . Created with Sketch. Andrew Forrest , or his entities have been involved with IXC since inception. This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Latest Posts. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. . ASX - By Stock. Created with Sketch. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. ASX - By Stock. ASX - Day TradingHere's a very good opportunity for people in Sydney. $100-200k might be the minimum for the market to take notice. . Below is the broker data for IXC November to. Created with Sketch. Been. The company can always acquire something new or do some capital returns. ASX - Day Trading. ASX - General. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC IXC chart IXC invex therapeutics ltd IXC chart 1 Last ralom 17,015 Posts. ASX - Day TradingCreated with Sketch. ASX - By Stock. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. , page-4. ASX - General. Withdrawal of AGM Resolutions, page-2. ASX - Short Term Trading. Join the HotCopper ASX share market forum today for free. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak: Tony Grist - 5th largest holder in IXC Tom Henderson - 2nd largest holder in IXC Kim Hogan - 6th largest holder in IXC and now Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. , page-5. Join the HotCopper ASX share market forum today for free. . It seems a massive hole within the industry of treatment *cough cough* IXC Also surprised by the amount of activity and people who have the disease.